Skip to content
Medical Health Aged Care, Seniors Interest

Media alert: February 26 – March 3 is Heart Valve Disease Awareness Week

hearts4heart 2 mins read

 A red and white logoDescription automatically generated with low confidence

  • Heart valve disease (HVD) affects more than half a million Australians, yet public awareness remains low. In fact, an estimated 250,000 Australians are unaware that they are living with the condition and this number is expected to grow significantly. 

  • If left untreated, HVD can damage the heart’s valves, leading to heart failure, stroke, and arrhythmia (an irregular heartbeat). 

  • Described by some researchers as 'the next cardiac epidemic', heart valve disease is on the rise due to an ageing population and under-diagnosis.
     
  • Early detection and timely treatment can increase longevity and improve quality of life for those living with HVD, making education and awareness of the disease vitally important. 

Monday, 12 February 2024, Sydney, Australia

In the lead up to Heart Valve Disease Awareness Week (February 26 – March 3), peak body hearts4heart, clinicians and people living with heart valve disease are urging Australians to have a heart-to-heart about their heart health with their GP, and for those over 65 or experiencing symptoms, to get their heart checked. 

Hearts4heart is proud to support free heart screening events during Heart Valve Disease Awareness Week at select hospitals in New South Wales and Victoria.  

The hospitals participating are: 

1. Victoria 

Hospital Name

Location

Date and Time

 

Melbourne Cardiac Services

 

 

Suite 7, 214 Burgundy Street, Heidelberg, VIC

 

 

Tuesday 27th February
(9am - 5pm AEDT)

 

 

North East Family Medicine Practice

 

 

Suite 1/90-100 Ovens Street, Wangaratta, VIC

 

 

Friday 1st March
(9am - 5pm AEDT)

 

 

2. New South Wales

Hospital Name

Location

Date and Time

 

St Vincent's Private Hospital *

 

 

406 Victoria Street, Darlinghurst, NSW

 

 

Wednesday 28th February
(8am - 2pm AEDT) 

Thursday 29th February
(10am - 4pm AEDT) 

 

 

* On Tuesday 27th February, 11am - 12:30pm AEDT, hearts4heart founder and CEO, Tanya Hall and Global Heart Hub CEO, Neil Johnson will be in attendance with a case study, clinician and local MP to speak to media about the importance of a heart check. 

 

 

Bankstown Sports Club 

 

 

8 Greenfield Parade, Bankstown, NSW 

 

 

Every day from Monday 26th February to Friday 1st March
(11am - 2pm AEDT) 

 

 

The Cardiac Centre, Bowral

 

 

3/28 Wingecarribee Street, Bowral, NSW

 

Thursday 7th March

(10am - 4pm AEDT)

 

 

 

 

-ENDS- 

Arranging interviews

We can line up interviews with a hearts4heart spokesperson, medical expert, or local case study living with the disease.   

 

Media assets  

We can assist you with a range of resources to help you build your story including content for TV, radio and online.

 

About Hearts4heart

Supported by Australian and New Zealand cardiologists, hearts4heart is a leading health promotion charity supporting, educating, and advocating for people living with heart disease. For more information visit hearts4heart.org.au 

  


Contact details:

Kerry Jung – kerry@palin.com.au 0435 753 618 

Annabel Pender - annabel@palin.com.au 0420 797 363

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.